Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University, Providence, RI, USA; Center for Alcohol and Addiction Studies, Department of Psychiatry and Human Behavior, Brown University, Providence, RI, USA; Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism, and National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
Department of Economics, Connecticut College, New London, CT, USA.
Addict Behav. 2021 Apr;115:106784. doi: 10.1016/j.addbeh.2020.106784. Epub 2020 Dec 16.
There is a lack of understanding of what contributes to attitudes toward individuals with an opioid addiction and preferences for policies that support them.
This study aimed to investigate stigmatization of an opioid addiction and support for publicly funded drug treatment. A randomized, between-subjects case vignette study (N = 1998) was conducted with a nation-wide online survey. To assess public perceptions of stigma and support for publicly funded drug treatment, participants rated a hypothetical individual who became addicted to prescription opioids across three conditions: 1) male or female, 2) an individual who was prescribed prescription painkillers or took prescription painkillers from a friend and 3) an individual who transitioned to using heroin or who continued using prescription painkillers.
Our results showed that there were stronger negative attitudes towards a male (p < .01) and toward an individual who took prescription painkillers from a friend (all p's < .05), and both stronger positive and negative attitudes toward an individual who transitioned to heroin from prescription painkillers (all p's < .05). Next, we demonstrated that the probability that someone supports publicly funded drug treatment increases by 3.6 percentage points for each unit increase along a 12-point scale of positive attitudes (p < .0005), 1.3 percentage points for each unit decrease along a 12-point scale of negative attitudes (p < .005), 7.3 percentage points for each unit increase along a 6-point scale of perceived treatment efficacy (p < .0001), 0.1 percentage points for each unit decrease along a 100-point scale that measures the strength of one's belief that addiction is controllable (p < .005) and 0.2 percentage points for each unit decrease along a 100-point scale that measures the strength of one's belief that income is controllable (p < .005). Lastly, when controlling for the effects of stigma, the probability of supporting publicly funded drug treatment decreases by 6.3 percentage points (p < 0.001) when an individual was prescribed prescription painkillers from a doctor. However, path analysis identified a channel through which a doctor's prescription increased support for publicly funded drug treatment by influencing positive attitudes, negative attitudes, and responsibility.
Our findings provide further evidence that information about individuals who become addicted to opioids can influence stigma perceptions and support for publicly funded drug treatment.
人们对于导致个体对阿片类药物成瘾的态度以及对支持此类个体的政策偏好缺乏了解。
本研究旨在调查对阿片类药物成瘾的污名化和对公共资助药物治疗的支持。通过全国性在线调查进行了一项随机、受试者间病例情节研究(N=1998)。为了评估公众对污名化和对公共资助药物治疗的支持,参与者在三种情况下对一个因处方类阿片药物成瘾的假设个体进行了评价:1)男性或女性,2)一个从医生那里开处方止痛药或从朋友那里拿处方止痛药的个体,3)一个从处方止痛药转为使用海洛因或继续使用处方止痛药的个体。
我们的研究结果表明,男性(p<0.01)和从朋友那里拿处方止痛药的个体(均 p<0.05)会受到更强烈的负面态度,而从处方止痛药转为使用海洛因的个体(均 p<0.05)则会受到更强烈的正面和负面态度。接下来,我们证明,沿着 12 分制的积极态度量表每增加一个单位,支持公共资助药物治疗的概率就会增加 3.6 个百分点(p<0.0005),沿着 12 分制的消极态度量表每减少一个单位,支持公共资助药物治疗的概率就会增加 1.3 个百分点(p<0.005),沿着 6 分制的感知治疗效果量表每增加一个单位,支持公共资助药物治疗的概率就会增加 7.3 个百分点(p<0.0001),沿着 100 分制的可控制性量表每减少一个单位,支持公共资助药物治疗的概率就会增加 0.1 个百分点(p<0.005),沿着 100 分制的可收入性量表每减少一个单位,支持公共资助药物治疗的概率就会增加 0.2 个百分点(p<0.005)。最后,当控制污名化的影响时,当个体从医生那里开处方止痛药时,支持公共资助药物治疗的概率会降低 6.3 个百分点(p<0.001)。然而,路径分析确定了一个渠道,即医生的处方通过影响积极态度、消极态度和责任感来增加对公共资助药物治疗的支持。
我们的研究结果进一步表明,关于个体成瘾的信息可以影响污名化认知和对公共资助药物治疗的支持。